0000899243-21-020294.txt : 20210520 0000899243-21-020294.hdr.sgml : 20210520 20210520210010 ACCESSION NUMBER: 0000899243-21-020294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210520 DATE AS OF CHANGE: 20210520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Anthony CENTRAL INDEX KEY: 0001606030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 21946336 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-19 0 0000730272 REPLIGEN CORP RGEN 0001606030 Hunt Anthony C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 1 0 0 Chief Executive Officer Common Stock 2021-05-19 4 S 0 612 168.29 D 212150 D Common Stock 2021-05-19 4 S 0 2529 169.45 D 209621 D Common Stock 2021-05-19 4 S 0 7911 170.28 D 201710 D Common Stock 2021-05-19 4 S 0 3420 171.32 D 198290 D Common Stock 2021-05-19 4 S 0 3036 172.52 D 195254 D Common Stock 2021-05-19 4 S 0 1560 173.19 D 193694 D Common Stock 2021-05-19 4 S 0 2819 174.41 D 190875 D Common Stock 2021-05-19 4 S 0 380 175.15 D 190495 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2020. $168.29 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.61 to $168.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $169.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.90 to $169.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $170.28 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.91 to $170.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $171.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.93 to $171.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $172.52 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.96 to $172.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $173.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.96 to $173.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $174.41 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $175.15 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.98 to $175.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Exhibit 24.1: Power of Attorney /s/ Kimberly Brown (Attorney in Fact) 2021-05-20 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT


                               POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints each of Jon Snodgres, Kimberly Brown and Kenneth O'Brien the true and
lawful attorney-in-fact and agent, with full power of substitution and
resubstitution, for the undersigned and in the undersigned's name, place and
stead, in any and all capacities (until revoked in writing) to execute for and
on behalf of the undersigned, in any and all of the undersigned's capacities,
any and all statements on Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by Repligen Corporation (the
"Company") in accordance with Sections 16(a) of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), and any and all regulations promulgated
thereunder, and to file the same, with all exhibits thereto, and any other
documents in connection therewith, with the Securities and Exchange Commission,
and with any other entity when and if such is mandated by the Exchange Act or by
the By-laws of the Financial Industry Regulatory Authority, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and
every act and thing requisite and necessary fully to all intents and purposes as
the undersigned might or could do in person thereby ratifying and confirming all
that said attorney-in- fact and agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of May 20, 2021.



                                 /s/ Anthony J. Hunt
                                 ----------------------------
                                 Name: Anthony J. Hunt